Companies: 10,795·Total market cap: $144.5T

InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc.

INMNASDAQHealthcare● Active

$1.54

$-0.04(-2.53%)

Market Cap$2787286

P/E Ratio—

52W High$5.5

52W Low$0.575

Avg Volume1.7M

Open$1.55

Beta0.97

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

InMed Pharmaceuticals Inc.（INM）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · INM · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1142.54Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$4.0MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding975,985Shares outstanding history

Next EarningsSep 18, 2026Est.Earnings history

探索 InMed Pharmaceuticals Inc. 数据

分析师预测$— · Buy

股息不分红

营收$4.9M+7.50%

盈利EPS $-8.36+58.49%

财务快照

FY 2025Revenue$4.9M▲ +7.50% YoY

202320242025

FY 2025Net Income-$8.2M▼ 6.34% YoY

202320242025

FY 2025EPS$-8.36▲ +58.49% YoY

202320242025

TTM:Revenue: $4.0MNet Income: -$9.9MEPS: $-1142.54View income statement →

分析师评级与目标价

Buy2 位分析师

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$1.54Current

$—Avg Target

$—High

合计: 2 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

InMed Pharmaceuticals Inc.

$1.54-2.53%$2.8M #2

Biodexa Pharmaceuticals Plc

$3.26-2.98%$54,688.89 #3

$1.67+4.38%$12.6M #4

CNS Pharmaceuticals, Inc.

$4.89-2.20%$2.8M #5

Estrella Immunopharma, Inc.

$1.13-0.88%$48.6M #6

Galmed Pharmaceuticals Ltd.

$0.47-32.57%$2.6M

股票表现

1D-2.53%

1W+2.67%

1M+136.92%

3M+67.39%

YTD+45.28%

1Y-45.96%

5Y-99.89%

关于 InMed Pharmaceuticals Inc.

CEOEric A. Adams Chem.

IPO DateMay 5, 2014

Employees13

CountryCA

Websiteinmedpharma.com

InMed Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical firm, concentrating its efforts on the investigation and creation of therapeutic solutions derived from cannabinoids. Its primary…

Biotechnology HealthcareNASDAQCA

关于股票概览与关键数据

InMed Pharmaceuticals Inc.（INM）是 Biotechnology 行业的 Healthcare 类公司，于 May 5, 2014 在 NASDAQ 上市。截至最近交易日，INM 股价为 $1.54，市值约为 $2.8M。过去12个月累计回报 -45.96%，年初至今回报 +45.28%。

根据 2 位华尔街分析师，InMed Pharmaceuticals Inc. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 InMed Pharmaceuticals Inc. 营收 $4.9M，净利润 -$8.2M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，InMed Pharmaceuticals Inc.（INM）股价为 $1.54，在 NASDAQ 上市，52周区间为 $0.57 – $5.50。

INM 最新股价INM quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议